Combinations of Janssen farnesyltransferase inhibitor with other chemotherapeutic agents Oct. 29, 2001
Feasibility of different schedule of administration assessed for ET-743 in clinical trial Oct. 29, 2001
SU-5416 may be useful in certain patients with c-kit-positive AML, according to phase II data Oct. 26, 2001
Antimicrotubule agent T-900607 well tolerated in ongoing phase I trial in advanced cancer patients Oct. 26, 2001
Novel platinum analogue shows evidence of activity, adequate safety in phase II cancer trials Oct. 26, 2001
RSS